Pharmafile Logo

Kate Tillett

- PMLiVE

MSD launches antibiotic combo Recarbrio in UK

Therapeutic indicated to treat infections caused by Gram-negative bacteria

- PMLiVE

Merck strengthens oncology pipeline with $2.75bn VelosBio deal

The deal will give Merck control of VLS-101, an antibody-drug conjugate

- PMLiVE

Merck, Bayer get FDA priority review for heart failure drug

Target action date set for January 2021

- PMLiVE

Porter Novelli wins first Best Use of Data Visualisation Award at Communiqué 2020

The winning initiative for this new category was created by Pfizer Oncology

- PMLiVE

Merck expands partnership with Zymeworks for multispecific antibodies

New licence agreement builds on existing collaboration

- PMLiVE

ENGINE MHP scores Charitable Campaign of the Year Award at Communiqué 2020

Campaign for Alzheimer’s Research UK was the clear winner

- PMLiVE

Porterhouse Medical Group – proud to be part of the first virtual Communiqué Awards 2020

At Porterhouse, we are always proud to support the Communiqué Awards, a leading healthcare and medical communications event that recognises the excellent work done by our global industry to communicate developments...

Porterhouse Medical Group

AstraZeneca AZ

EU gives AZ’s Lynparza green light for BRCA-mutated pancreatic cancer

PARP inhibitor now available for rare, life-threatening disease

- PMLiVE

OPEN Health scoops up Medical Affairs Agency Award at Communiqué 2020

Agency proves ongoing expertise in medical affairs at virtual awards

- PMLiVE

Mearns & Pike, Electric Putty and Evoke KYNE make a clean sweep at Communiqué 2020

Respective projects for Crohn’s and Colitis UK win across the board

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links